Docs' presidential preferences follow practice type
Solo practitioners favor Mitt Romney over Barack Obama by a two-to-one ratio, a survey finds, suggesting that changes in reimbursement driven by Obamacare are driving physicians' presidential preferences.
View ArticleVoting with their wallets, pharmas say no thanks to change
Barack Obama edged Mitt Romney in fundraising from pharmas in the 2012 election, even as the industry favored Republicans in other contests. Were change-weary drug companies voting for the status quo?
View ArticleFull steam ahead for Obamacare, but gridlock isn't going anywhere
President Obama has cemented his greatest legislative achievement, the Affordable Care Act, but the status quo should prove anything but boring, with implementation of the law sure to mean more...
View ArticleThe year ahead: A Capitol bit of crystal ball-gazing
From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store.
View ArticleCongress loses a healthcare mover, and pharma an unlikely ally on IPAB
The November elections were arguably the most important for healthcare policy in 40 years, cementing, as they did, the Affordable Care Act by awarding President Obama a second term. But with all eyes...
View ArticleSequester cuts could snarl approvals for years
With sequester cuts taking effect and no sign of a deal to end them in sight, FDA stands to lose 5% of its 2013 budget—though coming five months into the Federal fiscal year, it will feel more like...
View ArticleObama budget would bleed pharmas
The White House released its proposed budget for the 2014 fiscal year this morning, and while it gives a modest boost to Health and Human Services, it also seeks to extract more cost savings from pharmas.
View ArticleQ&A: BIO's Jim Greenwood
BIO chief Jim Greenwood talks policy priorities and previews the group's International Convention, now underway in Chicago.
View Article
